TAU-11071-78570
1 vaccination
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 272 / NC
- Registered
- 2021-07-24
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-07-22
Dose 1 — Moderna
-
2021-07-24
Registered in v-safe
-
2021-07-24
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Good · Site: Pain, Itching · HeadacheFree text: I did have symptoms the first two days. I was unaware that I couldn't report the symptoms from the first two days.MedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-22 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): I did have symptoms the first two days. I was unaware that I couldn't report the symptoms from the first two days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Adverse reaction | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release